A total of 120 Limulus amoebocyte lysate (LAL) determinations were made on plasma obtained from normal, healthy human blood donors. Results demonstrated a mean endotoxin level in blood of 0.02 to 1.57 pg/ml. The amount of Escherichia coli endotoxin added to human plasma samples can be quantitated by both nephelometry and turbidimetry. Endotoxin-spiked samples were shown to be significantly different from unspiked samples. When plasma samples were collected from 45 patients hospitalized at three centers, a strong association was demonstrated between a positive Limulus amoebocyte lysate assay and a septic condition.
The Limulus test described by Levin and Bang is the most sensitive method of detecting gram-negative bacterial endotoxin (J. Levin, Fed. Proc. 27:355, 1968 ). The Limulus amoebocyte lysate (LAL) assay has been widely used for in-process and final-release pyrogen testing of medical devices and large-and small-volume parenterals (12, 15) . Although the potential clinical utility of this assay has been encouraging for the rapid diagnosis of gram-negative bacterial meningitis (17) and urinary tract infections (9) , investigations remain divided on its usefulness in diagnosing gramnegative bacterial sepsis.
A number of LAL test inhibitors have been demonstrated in human plasma (10, 16, 21) . In an attempt to circumvent LAL test inhibition, various plasma treatments have been used, including chloroform extraction (11) , pH adjustment (5), platelet extraction (3), heat and dilution (2) , gel filtration (8) , ammonium sulfate precipitation (6) , ether extraction (7) , and addition of perchloric acid (13) .
The present study was undertaken to determine the average amount of circulating endotoxin in platelet-rich plasma (PRP) obtained from a population of healthy humans. It was also designed to ascertain whether endotoxin levels rise and fall at different times of the day, whether they are affected by fasting or varied meal intake, and whether Escherichia coli endotoxin added to samples of normal human plasma can be recovered and quantified. Two quantitative methods, nephelometry and turbidimetry, were used to measure endotoxin levels.
In another part of the study, PRP collected from hospitalized patients was subjected to the quantitative nephelometric procedure and to a newly introduced chromogenic procedure. (ii) Chromogenic. A daily working endotoxin standard was prepared in a depyrogenated test tube by adding 0.1 ml of a 50-ng/ml endotoxin solution to 10 ml of the Tween 20 (positive control diluent). This standard was prepared on the day it was to be used.
MATERIALS AND METHODS
Four endotoxin control concentrations were prepared in depyrogenated test tubes by diluting 1.0 ml of the 0.5-ng/ml endotoxin solution with 4.0 ml of positive control diluent (100 pg/ml). A 1.0-ml portion of the 100-pg/ml solution was used to prepare three serial twofold dilutions with the positive control diluent (50, 25, and 12.5 pg/ml). The positive control diluent was also used as a negative control. Samples (0.05 ml) of the negative control solution, the test sample, and each of the endotoxin control solutions were poured into three test tubes each. An additional 0.05 ml of positive control diluent was placed in one test tube to serve as the diluent blank. A 0.05-ml sample of each PRP tested served as the PRP blank (optical density reference blank).
The LAL vial was reconstituted with 3.0 ml of cold lysate diluent. The lysate (0.1 ml) was added to the opposite wall of tubes containing the negative controls, test samples, or endotoxin control standards, in that order. Reconstituted LAL diluent (0.1 ml) was added to all blanks. The test tubes were then covered with a sheet of Parafilm and agitated slightly to mix the samples, after which they were incubated in a 37 ± 0.5°C water bath or heating block for 10 min. On removal, the test tubes were placed in an ice bath.
Cold chromogenic substrate (0.5 ml) was added to all tubes. Tubes were agitated and placed in a 37 ± 0.5°C water bath for 15 Table 1 gives the endotoxin content, measured by nephelometric and turbidimetric techniques, of plasma samples taken from 30 normal human subjects after overnight fasting and after lunch. Quantitation was performed by comparison with control curves obtained by measuring negative human plasma spiked with E. coli 055:B5 endotoxin at 0, 25, 50, 100, and 200 pg/ml. The turbidimetric analysis did not detect any significant differences between the endotoxin equiva- lents in samples taken from the fasted and non-fasted subjects.
RESULTS
For the nephelometric procedure, samples taken from 7 of the 30 non-fasted patients gave nonzero results. For all seven, the result obtained from non-fasted patients exceeded that obtained from fasted patients. Although this difference is statistically significant (P < 0.01 for a sign test), the magnitude of the differences has little practical significance.
The samples that were taken from the same donors and spiked with E. coli endotoxin at a level of 1,000 pg/ml were analyzed in a blind fashion by both instrumental techniques. The results of this study are given in Table 2 , along with mean estimates of the endotoxin equivalents of the unspiked samples.
Results of analyses of individual samples from hospitalized patients are shown in Table 3 . A total of 17 LAL determinations were made on patients who had samples that were either LAL positive or culture positive (7 patients tested by the nephelometric LAL assay and 10 patients tested by the chromogenic LAL assay). Of the 17 patients, 5 had gram-positive culture-proven bacteremia, and their samples exhibited a negative LAL result. Since there are reports of LAL-positive results in the presence of gram-positive culture-proven bacteremia, the latter finding is encouraging with regard to test specificity (18, 19) . Of samples taken from 10 patients having culture-proven gram-negative bacteremia, one sample was negative by LAL. Two individuals had samples that were LAL positive and culture negative. An additional 27 PRP samples collected from hospitalized patients were found to be blood culture negative and negative by the LAL assay. Overall results for the hospitalized patients are summarized in Table 4 DISCUSSION The results of this study demonstrate that plasma taken from healthy donors does not contain significant amounts of endotoxin when assayed by the test systems reported here. E. coli 055:B5 added to the plAsma of the same individuals could be recovered when the plasma was diluted 1:10 and treated at 70°C for 10 min. By using the same plasma sample preparation technique, we could detect endotoxin in the majority of patients also having culture-proven gram-negative bacteremia. Both the nephelometric and chromogenic LAL methodologies appear to be equally effective. These results tend to confirm and extend the studies of Cooperstock et al. (2) and Das et al. (3) . Five plasma samples from patients with culture-proven gram-positive bacteremia were LAL negative. These results, which suggest LAL test specificity for endotoxin, do not agree with the results of other studies (4, 19) . However, it should be kept in mind that LAL test results are specific to the test methodology used and probably are also specific to the LAL reagent used as well. There are major manufacturing differences among commercial LAL reagents. These manufacturing differences clearly lead to differences in test results when various commercial lysates are compared by using the same test substance (14, 18, 20) . This observation could also hold true for the interaction of plasma with various commercial LAL assays. This is the first time that data have been published on the Travenol LAL reagent for the detection of endotoxin in plasma. This reagent is not commercially available.
The results of these initial studies are encouraging with regard to LAL test specificity and sensitivity. The findings suggest that the clinical utility of the LAL test for the detection of gram-negative sepsis should be reevaluated in light of new information, modified reagents, and revised test systems.
